BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16717241)

  • 21. Routine investigations of the CSF with special reference to meningeal malignancy and infectious meningitis.
    van Zanten AP; Twijnstra A; Ongerboer de Visser BW
    Acta Neurol Scand; 1988 Mar; 77(3):210-4. PubMed ID: 3376745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leptomeningeal lymphoma in a child with acquired immune deficiency syndrome.
    Scrigni A; Nastri M; Rodríguez de Schiavi S; Czornyj L; Felice M; Mantese B
    Neuropediatrics; 2006 Jun; 37(3):121-5. PubMed ID: 16967361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma.
    Alexandrakis MG; Sfiridaki A; Miyakis S; Pappa C; Kandidaki E; Alegakis A; Margioris AN
    Clin Chim Acta; 2007 Apr; 379(1-2):31-5. PubMed ID: 17234170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor as a marker of disease activity in neurotuberculosis.
    Husain N; Awasthi S; Haris M; Gupta RK; Husain M
    J Infect; 2008 Feb; 56(2):114-9. PubMed ID: 18158186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longterm meningeal involvement as the only clinical manifestation of low grade malignant non-Hodgkin's lymphoma.
    Heimans JJ; Wijermans PW; Polman CH; Huijgens PC; Ossenkoppele GJ; van Kamp GJ
    J Neurooncol; 1990 Dec; 9(3):275-7. PubMed ID: 2086741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin.
    Tanaka Y; Abe M; Hiasa M; Oda A; Amou H; Nakano A; Takeuchi K; Kitazoe K; Kido S; Inoue D; Moriyama K; Hashimoto T; Ozaki S; Matsumoto T
    Clin Cancer Res; 2007 Feb; 13(3):816-23. PubMed ID: 17289872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased urokinase-type plasminogen activator receptor and epidermal growth factor receptor in serum of patients with prostate cancer.
    Milanese G; Dellabella M; Fazioli F; Pierpaoli E; Polito M; Siednius N; Montironi R; Blasi F; Muzzonigro G
    J Urol; 2009 Mar; 181(3):1393-400. PubMed ID: 19157433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal Fluid Cytological Diagnosis in Multiple Myeloma With Leptomeningeal Involvement: A Report of Two Cases.
    Ren H; Zou Y; Zhao Y; Li J; Han X; He J; Guan H
    Diagn Cytopathol; 2017 Jan; 45(1):66-68. PubMed ID: 27628930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostaglandin E2 regulates tumor angiogenesis in prostate cancer.
    Jain S; Chakraborty G; Raja R; Kale S; Kundu GC
    Cancer Res; 2008 Oct; 68(19):7750-9. PubMed ID: 18829529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
    Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
    Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer.
    Vidal O; Metges JP; Elizalde I; Valentíni M; Volant A; Molina R; Castells A; Pera M
    Br J Surg; 2009 Dec; 96(12):1443-51. PubMed ID: 19918848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-alpha inhibits in vitro osteoclast differentiation and renal cell carcinoma-induced angiogenesis.
    Avnet S; Cenni E; Perut F; Granchi D; Brandi ML; Giunti A; Baldini N
    Int J Oncol; 2007 Feb; 30(2):469-76. PubMed ID: 17203230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour-associated angiogenesis in human colorectal cancer.
    Rmali KA; Puntis MC; Jiang WG
    Colorectal Dis; 2007 Jan; 9(1):3-14. PubMed ID: 17181841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Angiogenesis and hematologic malignancy].
    Zini JM; Tobelem G
    Bull Cancer; 2007 Jul; 94 Spec No():S241-6. PubMed ID: 17846010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leptomeningeal metastases from leukemias and lymphomas.
    Nolan CP; Abrey LE
    Cancer Treat Res; 2005; 125():53-69. PubMed ID: 16211883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CSF protein profiling using Multiplex Immuno-assay: A potential new diagnostic tool for leptomeningeal metastases.
    Brandsma D; Voest EE; de Jager W; Bonfrer H; Algra A; Boogerd W; Korse T; Reijneveld JC; Verbeek MM; Rijkers G; Taphoorn MJ
    J Neurol; 2006 Sep; 253(9):1177-84. PubMed ID: 16998648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Large B-cell non-Hodgkin lymphoma relapsing with meningeal localization.
    Massa A; Fozza C
    Blood; 2012 Jun; 119(26):6185. PubMed ID: 22928191
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of gelatinases (MMP-2 and MMP-9), TIMP-1, vascular endothelial growth factor (VEGF), and microvessel density on the clinicopathological behavior of childhood non-Hodgkin lymphoma.
    Citak EC; Oguz A; Karadeniz C; Akyurek N
    Pediatr Hematol Oncol; 2008; 25(1):55-66. PubMed ID: 18231955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Specific meningeal involvement in multiple myeloma].
    Korinek A; Solal-Celigny P; Kuentz M; Farcet JP; Clauvel JP
    Presse Med; 1985 Mar; 14(13):733-6. PubMed ID: 3157976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.